Mirror Medacta Shoulder System Pivotal Trial

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Arthritis Shoulder Clinical Trial

Official title:
Multicentric, Prospective, Comparative Trial to Assess the Efficacy and Safety of an Anatomic Total Shoulder System.

Status Recruiting

Clinical Trial Summary

The purpose of this study is to demonstrate safety and efficacy of the Mirror Medacta Shoulder System in total shoulder arthroplasty.

n/a

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04629391` - Anatomic TSA vs RTSA for Glenohumeral Arthritis	N/A
Recruiting	`NCT05297305` - Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty	N/A
Recruiting	`NCT04728282` - Comparison of Lateralized RTSA With and Without Subscapularis Repair	Early Phase 1
Recruiting	`NCT04949087` - Efficacy of Intra-articular Injections for the Treatment of Primary Glenohumeral Osteoarthritis(GHOA)	N/A
Recruiting	`NCT06080412` - Blueprint® Mixed Reality Pilot Study